nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—CYP2C9—cardial valve—dilated cardiomyopathy	0.788	0.788	CbGeAlD
Lumiracoxib—PTGS1—myocardium—dilated cardiomyopathy	0.0569	0.0569	CbGeAlD
Lumiracoxib—CYP2C9—heart—dilated cardiomyopathy	0.0435	0.0435	CbGeAlD
Lumiracoxib—PTGS1—heart—dilated cardiomyopathy	0.0397	0.0397	CbGeAlD
Lumiracoxib—PTGS2—heart—dilated cardiomyopathy	0.038	0.038	CbGeAlD
Lumiracoxib—PTGS1—cardiac atrium—dilated cardiomyopathy	0.034	0.034	CbGeAlD
